Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells.

Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid metabolite abundantly stored in platelets and released upon platelet activation. Recently, S1P has been postulated for its potential roles in angiogenesis. In this study, we provided several lines of evidence showing that S1P has angiogenic activity. In vitro, S1P stimulated DNA synthesis and chemotactic motility of human umbilical vein endothelial cells (HUVECs) in a dose-dependent manner, reaching a near maximum at 1 microM. S1P also significantly induced tube formation of HUVECs on Matrigel. Matrigel plug assay in mice revealed that S1P promotes angiogenesis in vivo. In addition, exposure of HUVECs to S1P led to rapid activation of extracellular signal-regulated kinases (ERKs) and p38 mitogen-activated protein kinase (p38 MAPK) in a pertussis toxin (PTX)-sensitive manner. Notably, HUVEC migration and tube formation in response to S1P were completely blocked by pretreatment with PTX. Further, the MEK inhibitor U0126 markedly inhibited S1P-induced tube formation but S1P-induced migration was not affected by inhibition of ERK and p38 MAPK. Taken together, these results indicate that S1P induces angiogenesis predominantly via G(i) protein-coupled receptors in endothelial cells and suggest that S1P may act as an important modulator of platelet-induced angiogenesis.

[1]  T. Hla,et al.  An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. , 1990, The Journal of biological chemistry.

[2]  Henry R. Bourne,et al.  Receptors induce chemotaxis by releasing the βγ subunit of Gi, not by activating Gq or Gs , 1997 .

[3]  J. Folkman,et al.  Involvement of platelets in tumour angiogenesis? , 1998, The Lancet.

[4]  T. Hla,et al.  Lysophosphatidic Acid Stimulates the G-protein-coupled Receptor EDG-1 as a Low Affinity Agonist* , 1998, The Journal of Biological Chemistry.

[5]  Y. Igarashi,et al.  Sphingosine 1-phosphate is a blood constituent released from activated platelets, possibly playing a variety of physiological and pathophysiological roles. , 1998, Acta biochimica Polonica.

[6]  A. Mantovani,et al.  Molecular mechanisms of blood vessel formation. , 1997, Trends in biochemical sciences.

[7]  Y. Igarashi,et al.  Sphingosine 1-Phosphate Induces Platelet Activation through an Extracellular Action and Shares a Platelet Surface Receptor with Lysophosphatidic Acid* , 1997, The Journal of Biological Chemistry.

[8]  Y. Yatomi,et al.  Induction and suppression of endothelial cell apoptosis by sphingolipids: a possible in vitro model for cell-cell interactions between platelets and endothelial cells. , 1999, Blood.

[9]  S. Mahooti,et al.  Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. , 1998, Journal of cell science.

[10]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[11]  Jacques Landry,et al.  p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells , 1997, Oncogene.

[12]  K. Honn,et al.  12(S)-HETE is a mitogenic factor for microvascular endothelial cells: its potential role in angiogenesis. , 1995, Biochemical and biophysical research communications.

[13]  J. Jackson,et al.  The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. , 1998, Biochimica et biophysica acta.

[14]  H. Bourne,et al.  Gαi Is Not Required for Chemotaxis Mediated by Gi-coupled Receptors* , 1999, The Journal of Biological Chemistry.

[15]  E. Goetzl,et al.  Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1‐phosphate , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[17]  S. Hakomori,et al.  Sphingosine 1-phosphate regulates melanoma cell motility through a receptor-coupled extracellular action and in a pertussis toxin-insensitive manner. , 1997, Biochemistry.

[18]  Activation of blood coagulation in cancer: Trousseau's syndrome revisited , 1983 .

[19]  C. H. Liu,et al.  Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. , 1998, Science.

[20]  S. Hakomori,et al.  Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. , 1995, Blood.

[21]  E. Goetzl,et al.  Signaling mechanisms and molecular characteristics of G protein‐coupled receptors for lysophosphatidic acid and sphingosine 1‐phosphate , 1998, Journal of cellular biochemistry. Supplement.

[22]  S. Hakomori,et al.  Sphingosine 1-phosphate, a specific endogenous signaling molecule controlling cell motility and tumor cell invasiveness. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[24]  K. W. Kim,et al.  Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma. , 1998, Cancer research.

[25]  E. Papadimitriou,et al.  Evidence that platelets promote tube formation by endothelial cells on matrigel , 1998, British journal of pharmacology.

[26]  D. Linzer,et al.  Proliferin induces endothelial cell chemotaxis through a G protein-coupled, mitogen-activated protein kinase-dependent pathway. , 1997, Endocrinology.

[27]  D. Willoughby,et al.  The codependence of angiogenesis and chronic inflammation , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  E. Krebs,et al.  Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: spatial and temporal modulation of PDGF chemotactic signal transduction , 1995, The Journal of cell biology.

[29]  P. Gullino,et al.  Role of prostaglandin E1 and copper in angiogenesis. , 1982, Journal of the National Cancer Institute.

[30]  S. Spiegel,et al.  Involvement of focal adhesion kinase in inhibition of motility of human breast cancer cells by sphingosine 1-phosphate. , 1999, Experimental cell research.

[31]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.